Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 323
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05526742 | A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects | ||
| NCT02801526 | Bioequivalence Study (Candesartan 16 mg and Amlodipine 5 mg) - A | ||
| NCT07532148 | Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ||
| NCT02288338 | CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers | ||
| NCT05952219 | Study to Evaluate the Safety and Pharmacokinetics of CKD-379 | ||
| NCT04667975 | The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy | ||
| NCT04867200 | A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers | ||
| NCT03382756 | A Clinical Trial to Assess the Effects of Food on the Bioavailability of CKD-337 | ||
| NCT03076957 | A Phase 1/2a Study to Assess the Safety and Efficacy of CKD-516 Tab. in Combination With Irinotecan Inj. | ||
| NCT04703374 | A Study to Compare PK, PD and Safety of CKD-382 in Healthy Subjects | ||
| NCT02623868 | Study to Assess PK/PD Character, Safety/Tolerability of CKD-519 New Formulation in Healthy Male Subject. | ||
| NCT06386328 | A Clinical Trial to Evaluate the Food Effect of CKD-378 | ||
| NCT01496261 | Comparative Pharmacokinetics Study of Clopidogrel and Aspirin Fixed-dose Combination Versus Separate Combination-2nd Trial | ||
| NCT03762369 | A Clinical Study to Evaluate the Efficacy and Safety of CKD-351 | ||
| NCT05089279 | Study to Evaluate the Safety and Pharmacokinetics of CKD-349 in Healthy Adult Volunteers | ||
| NCT03601910 | Clinical Study to Compare the Pharmacokinetic Characteristics and Safety Between CKD-380 10mg and D308 10mg | ||
| NCT07577518 | Comparison of the Incidence of Major Cardiovascular Events Between the Combination of Percutaneous Intervention and Optimal Drug Therapy and the Optimal Drug Therapy Alone in Patients With Chronic Coronary Syndrome | ||
| NCT06709807 | Clinical Study to Evaluate the Food Effect of CKD-378 in Healthy Volunteers | ||
| NCT03382795 | Retreatment With Epidermal Growth Factor Receptor(EGFR) Tyrosine Kinase Inhibitor in EGFR Mutation Positive Patients | ||
| NCT03749356 | Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients | ||
| NCT04660370 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 | ||
| NCT02247505 | CKD-397 Drug-drug Interaction Study (B) | ||
| NCT06431477 | Efficacy and Safety of Telmisartan Compared With Losartan | ||
| NCT03849261 | Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 in Healthy Adults | ||
| NCT02005744 | A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic Function | ||
| NCT03609606 | A Study to Investigate Drug Interaction Between D326, D337, and D013 in Healthy Male Subjects | ||
| NCT03346187 | A Clinical Trial to Compare Safety and Pharmacokinetic Characteristics of CKD-337 | ||
| NCT04746287 | Evaluation of the Safety and Tolerability of CKD-510 in Healthy Subjects | ||
| NCT04906785 | Clinical Study to Investigate the PK Profiles and Safety of CKD-385 in Healthy Volunteers Under Fed Conditions | ||
| NCT03950843 | A Clinical Trial to Evaluate the Efficacy and Safety of CKD-825 in Patients With Atrial Fibrillation | ||
| NCT03175835 | Study to Evaluate the Drug Interaction Between CKD-519 and Rosuvastatin in Healthy Male Subjects | ||
| NCT06627322 | A Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH) | ||
| NCT05193565 | Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients | ||
| NCT02977065 | To Assess the Safety, Efficacy and Tolerability of CKD-519, Administered With HMG-CoA Reductase Inhibitors | ||
| NCT04700709 | Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients. | ||
| NCT02064621 | CKD-330 Drug-Drug Interaction Study (Candesartan) | ||
| NCT03583905 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-333 Tablet | ||
| NCT02631954 | Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy Volunteers | ||
| NCT06838286 | Korean Study on Safety and Effectiveness of OAD Triple Therapy in Type 2 Diabetes | ||
| NCT02648854 | Investigate the Effect of Food on the Pharmacokinetic Characteristics of CKD-395 in Healthy Male Volunteers | ||
| NCT01497873 | A Randomized Study to Compare the Efficacy and Safety of Belotecan and Topotecan as Monotherapy for Sensitive-Relapsed Small Cell Lung Cancer | ||
| NCT01369472 | Evaluating Dose-proportionality of Dilatrend Suspended-Release Capsule | ||
| NCT04883658 | A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) | ||
| NCT02451098 | Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 | ||
| NCT03034486 | The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930 | ||
| NCT02777723 | Study to Evaluate the Efficacy and Safety of CKD-350 | ||
| NCT01028859 | Safety Study of Increasing Doses of CKD-516 in Patients With Advanced Solid Cancers | ||
| NCT03536780 | Avelumab in Combination With Gemcitabine in Advanced Leiomyosarcoma as a Second-line Treatment | ||
| NCT01910077 | Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg | ||
| NCT05719155 | Pharmacokinetics and Safety/Tolerability of CKD-379 |
